# Paradigm Shift in the Treatment of Patients With ACS

> **NCT02041650** · PHASE4 · COMPLETED · sponsor: **Yu Bo** · enrollment: 250 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02041650
- **Lead sponsor:** Yu Bo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-04
- **Final completion:** 2017-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2018-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02041650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02041650, "Paradigm Shift in the Treatment of Patients With ACS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02041650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*